News Update: Allergan (NYSE:AGN) Jumps on FDA Approval for Botox Spasm Treatment Application

From: TradeTheTrend

Added: 16 years ago · 1:08 · 480p

3/10/2010-Shares of Allergan (NYSE:AGN) are trading 1.6% higher to $62.34 Wednesday after the health-care company's Botox ...